Phase II study of pirarubicin in advanced non-small cell lung cancer.
Berthaud
P
P
Département de Médecine, Institut Gustave-Roussy, Villejuif, France.
Le Chevalier
T
T
Berille
J
J
Herait
P
P
Baldeyrou
P
P
Tursz
T
T
Arriagada
R
R
Spielmann
M
M
Hayat
M
M
D000328:Adult; D000368:Aged; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D004317:Doxorubicin / Q000031:analogs & derivatives; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged
D004317:Doxorubicin; C027260:pirarubicin